Covid 19 Research using Clinical Trials (Home Page)
measurement of circulating sFlt1 concentrationWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (0)
|
Name (Synonyms) |
Correlation |
Correlated MeSH Terms (2)
|
Name (Synonyms) |
Correlation |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.06 |
D018352 | Coronavirus Infections NIH | 0.05 |
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
Short description of the protocol intended for the lay public. Include a brief statement of
the study hypothesis (Limit : 5000 characters) The management of critically-ill patients with
organ failure due to COVID-19 represents a major healthcare burden. While endothelial
inflammation has been reported in these patients, the pathophysiological mechanisms remain
incompletely elucidated.
Primary Outcomes
Measure: Association between concentration of circulating sFlt1 and use of vasopressor Time: 14 days
No related HPO nodes (Using clinical trials)